HCPCS Level IIdrugActive
J0179
Inj, brolucizumab-dbll, 1 mg
BETOS: O1E
Effective: 2020-01-01
Referenced in 1 policies
Description
Injection, brolucizumab-dbll, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Beovu
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
1 MG
Billing Units
6.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.